149 related articles for article (PubMed ID: 2502699)
21. Mn-DPDP-enhanced 24-h delayed-scan MRI of hepatocellular carcinoma is correlated with histology.
Wang DB; Zhou KR; Zeng MS; Chen KM; Wang YX
Eur Radiol; 2004 Apr; 14(4):743-5. PubMed ID: 12802614
[No Abstract] [Full Text] [Related]
22. Normal and infarcted myocardium: differentiation with cellular uptake of manganese at MR imaging in a rat model.
Bremerich J; Saeed M; Arheden H; Higgins CB; Wendland MF
Radiology; 2000 Aug; 216(2):524-30. PubMed ID: 10924581
[TBL] [Abstract][Full Text] [Related]
23. Role of exocrine cells in pancreatic enhancement using Mn-DPDP-enhanced MR imaging.
Gong J; Xu J; Zhou K; Shen K
Chin Med J (Engl); 2002 Sep; 115(9):1363-6. PubMed ID: 12411113
[TBL] [Abstract][Full Text] [Related]
24. Comparison of gadolinium chelates with manganese-DPDP for liver lesion detection and characterization: preliminary results.
Kettritz U; Schlund JF; Wilbur K; Eisenberg LB; Semelka RC
Magn Reson Imaging; 1996; 14(10):1185-90. PubMed ID: 9065909
[TBL] [Abstract][Full Text] [Related]
25. Effects of MnDPDP, DPDP--, and MnCl2 on cardiac energy metabolism and manganese accumulation. An experimental study in the isolated perfused rat heart.
Brurok H; Schjøtt J; Berg K; Karlsson JO; Jynge P
Invest Radiol; 1997 Apr; 32(4):205-11. PubMed ID: 9101355
[TBL] [Abstract][Full Text] [Related]
26. Hepatic MR imaging with Mn-DPDP: safety, image quality, and sensitivity.
Bernardino ME; Young SW; Lee JK; Weinreb JC
Radiology; 1992 Apr; 183(1):53-8. PubMed ID: 1549694
[TBL] [Abstract][Full Text] [Related]
27. Mn-DPDP-enhanced MR imaging of malignant liver lesions: efficacy and safety in 20 patients.
Aicher KP; Laniado M; Kopp AF; Grönewäller E; Duda SH; Claussen CD
J Magn Reson Imaging; 1993; 3(5):731-7. PubMed ID: 8400558
[TBL] [Abstract][Full Text] [Related]
28. Magnetic resonance with manganese-DPDP (mangafodipir) of focal solid pancreatic lesions.
Zanello A; Nicoletti R; Brambilla P; Boccuni R; Di Carlo V; Staudacher C; Del Maschio A
Radiol Med; 2004 Sep; 108(3):194-207. PubMed ID: 15343134
[TBL] [Abstract][Full Text] [Related]
29. MRI for detection of hepatocellular carcinoma: comparison of mangafodipir trisodium and gadopentetate dimeglumine contrast agents.
Youk JH; Lee JM; Kim CS
AJR Am J Roentgenol; 2004 Oct; 183(4):1049-54. PubMed ID: 15385303
[TBL] [Abstract][Full Text] [Related]
30. Benign and malignant hepatocellular tumors: evaluation of tumoral enhancement after mangafodipir trisodium injection on MR imaging.
Coffin CM; Diche T; Mahfouz A; Alexandre M; Caseiro-Alves F; Rahmouni A; Vasile N; Mathieu D
Eur Radiol; 1999; 9(3):444-9. PubMed ID: 10087113
[TBL] [Abstract][Full Text] [Related]
31. Comparison between Gd-DTPA, Gd-EOB-DTPA, and Mn-DPDP in induced HCC in rats: a correlation study of MR imaging, microangiography, and histology.
Marchal G; Zhang X; Ni Y; Van Hecke P; Yu J; Baert AL
Magn Reson Imaging; 1993; 11(5):665-74. PubMed ID: 8345781
[TBL] [Abstract][Full Text] [Related]
32. Functioning acinar cell pancreatic carcinoma: diagnosis on mangafodipir trisodium (Mn-DPDP)-enhanced MRI.
Sahani D; Prasad SR; Maher M; Warshaw AL; Hahn PF; Saini S
J Comput Assist Tomogr; 2002; 26(1):126-8. PubMed ID: 11801915
[TBL] [Abstract][Full Text] [Related]
33. Pancreatic contrast enhancement with Mn-bis pyridoxal ethylene diamine diacetic acid and the influence of a hormonal stimulation of the pancreas in pigs.
Blume J; Palmié S; Aue B; Spielmann RP; Sievers E; Lodemann KP; Heller M
Acad Radiol; 1994 Nov; 1(3):253-60. PubMed ID: 9419495
[TBL] [Abstract][Full Text] [Related]
34. Magnetic resonance imaging of acute myocardial ischemia using a manganese chelate, Mn-DPDP.
Pomeroy OH; Wendland M; Wagner S; Derugin N; Holt WW; Rocklage SM; Quay S; Higgins CB
Invest Radiol; 1989 Jul; 24(7):531-6. PubMed ID: 2502502
[TBL] [Abstract][Full Text] [Related]
35. Accumulation of manganese in the brain of mice after intravenous injection of manganese-based contrast agents.
Gallez B; Baudelet C; Adline J; Geurts M; Delzenne N
Chem Res Toxicol; 1997 Apr; 10(4):360-3. PubMed ID: 9114970
[TBL] [Abstract][Full Text] [Related]
36. [Manganese DPDP as a contrast medium for MR tomography of focal liver lesions. Tolerance and image quality in 20 patients].
Kopp AF; Laniado M; Aicher KP; Grönewäller EF; Claussen CD
Rofo; 1992 Dec; 157(6):539-47. PubMed ID: 1457788
[TBL] [Abstract][Full Text] [Related]
37. Adrenal gland enhancement at MR imaging with Mn-DPDP.
Mitchell DG; Outwater EK; Matteucci T; Rubin DL; Chezmar JL; Saini S
Radiology; 1995 Mar; 194(3):783-7. PubMed ID: 7862979
[TBL] [Abstract][Full Text] [Related]
38. Cirrhosis of the liver: MR imaging with mangafodipir trisodium (Mn-DPDP).
Murakami T; Baron RL; Federle MP; Peterson MS; Oliver JH; Davis PL; Confer SR
Radiology; 1996 Feb; 198(2):567-72. PubMed ID: 8596867
[TBL] [Abstract][Full Text] [Related]
39. MR imaging of pancreatic lesions. Comparison of manganese-DPDP and gadolinium chelate.
Diehl SJ; Lehmann KJ; Gaa J; McGill S; Hoffmann V; Georgi M
Invest Radiol; 1999 Sep; 34(9):589-95. PubMed ID: 10485075
[TBL] [Abstract][Full Text] [Related]
40. Hepatocellular tumors: characterization with Mn-DPDP-enhanced MR imaging.
Rofsky NM; Weinreb JC; Bernardino ME; Young SW; Lee JK; Noz ME
Radiology; 1993 Jul; 188(1):53-9. PubMed ID: 8390072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]